Redmond Regional Medical Centre supplying monoclonal antibody treatment |

Redmond Regional Medical Centre supplying monoclonal antibody treatment |

Redmond Regional Medical Middle is now presenting Bamlanivimab antibody infusions to non-hospitalized individuals who have tested beneficial for COVD-19 and have other substantial-possibility variables. The U.S. Foods and Drug Administration granted Emergency Use Authorization of Bamlanivimab for the treatment of COVID-19 in clients enduring gentle to reasonable indications who are significant-chance to acquire critical COVID-19. […]

Continue Reading